Benzbromarone
- Generic Name
- Benzbromarone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H12Br2O3
- CAS Number
- 3562-84-3
- Unique Ingredient Identifier
- 4POG0RL69O
- Background
Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia, Chronic Kidney Disease, Abnormal Renal Function, and Gout and Asymptomatic Hyperuricemia.
- Indication
本品为强有力的促尿酸排泄药，适用于反复发作的痛风性关节炎伴高尿酸血症及痛风石。
- Associated Conditions
- Gout
- Associated Therapies
- -
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- InventisBio Co., Ltd
- Target Recruit Count
- 121
- Registration Number
- NCT05504083
- Locations
- 🇨🇳
Inner Mongolia Baogang Hospital, Baotou, China
🇨🇳Beijing Chao-yang Hospital, Capital Medical University, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, China
Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 198
- Registration Number
- NCT03185793
- Locations
- 🇨🇳
Jiangsu Hengrui Medicine Co., Ltd., Shanghai, Shanghai, China
Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
- Conditions
- Interventions
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Fuji Yakuhin Co., Ltd.
- Target Recruit Count
- 201
- Registration Number
- NCT03100318
- Locations
- 🇯🇵
Tokyo, Tokyo, Japan
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
- Conditions
- Interventions
- First Posted Date
- 2016-10-25
- Last Posted Date
- 2016-10-25
- Lead Sponsor
- Shanghai 10th People's Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT02944214
- Locations
- 🇨🇳
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai, Shanghai, China
Acute Effects of Benzbromaron on the Pulmonary Circulation
- Conditions
- Interventions
- First Posted Date
- 2016-06-03
- Last Posted Date
- 2016-12-23
- Lead Sponsor
- Medical University of Graz
- Target Recruit Count
- 10
- Registration Number
- NCT02790450
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
Compare the Renal Protective Effects of Febuxostat and Benzbromarone
- Conditions
- Interventions
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Shanghai 10th People's Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT02338323
- Locations
- 🇨🇳
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai, Shanghai, China
A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients
- Conditions
- Interventions
- First Posted Date
- 2014-12-17
- Last Posted Date
- 2015-06-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 110
- Registration Number
- NCT02317861
- Locations
- 🇯🇵
Research Site, Fukuoka-shi, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.